Showing 1,454 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

New Twist in the Gilead Patent Lawsuit Over Truvada and Descovy to Prevent HIV

Editor's pick
POZ
8 January 2021
Pharmaceutical industry

Counterfeit HIV Med Symtuza Found in Three U.S. Pharmacies

Editor's pick
POZ
3 January 2021
Injectable & long-acting HIV treatment

ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe

Editor's pick
ViiV Healthcare press release
21 December 2020
Access to healthcare

Cheaper HIV treatment for children

Editor's pick
The Lancet (free registration required)
11 December 2020
New & experimental HIV treatments

ViiV Healthcare announces positive CHMP opinion for Rukobia (fostemsavir), a first-in-class attachment inhibitor for the treatment of adults with multidrug-resistant HIV with few treatment options available

Editor's pick
ViiV Healthcare press release
11 December 2020
Access to healthcare

New ViiV license with the Medicines Patent Pool expands access but eviscerates transparency

Editor's pick
Health GAP (Global Access Project)
8 December 2020
PrEP policies & guidelines

HIV prevention drugs illustrate just how bad pharmaceutical patents are for our health

Editor's pick
NBC News
3 December 2020
Combatting stigma

ViiV Healthcare and Shutterstock Studios unite to tackle outdated perceptions of HIV with ‘HIV in View’ - a first-of-its-kind online HIV photography gallery

Editor's pick
ViiV Healthcare press release
1 December 2020
New & experimental HIV treatments

Data sets up 2021 filings for Gilead's twice-a-year HIV drug lenacapavir

Editor's pick
Pharmaphorum
20 November 2020
New & experimental HIV treatments

Gilead Announces Investigational Long-Acting HIV-1 Capsid Inhibitor, Lenacapavir, Achieves Primary Endpoint in Phase 2/3 Study in Heavily Treatment-Experienced People Living With HIV

Editor's pick
Gilead press release
20 November 2020
Injectable & long-acting PrEP

ViiV Healthcare receives FDA Breakthrough Therapy Designation for investigational, long-acting cabotegravir for HIV prevention

Editor's pick
ViiV press release
17 November 2020
Injectable & long-acting PrEP

Merck Launches Major Trial of Monthly Islatravir PrEP Pill for Women

Editor's pick
POZ
16 November 2020
Clinical trials

Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry

Editor's pick
FDA
10 November 2020
Pharmaceutical industry

GlaxoSmithKline's HIV PrEP challenge looms as ViiV's long-acting drug tops Gilead's Truvada in women

Editor's pick
FiercePharma
10 November 2020
Injectable & long-acting HIV treatment

ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV

Editor's pick
ViiV Healthcare press release
16 October 2020
Treatment simplification strategies

GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen

Editor's pick
FiercePharma
7 October 2020
Pharmaceutical industry

US: Gilead's Truvada faces Teva generics assault amid Descovy switching campaign

Editor's pick
FiercePharma
4 October 2020
Pharmaceutical industry

First Generic Truvada Now Available in the United States

Editor's pick
POZ
4 October 2020
Pharmaceutical industry

US: PrEP Costs Must Come Down for Uptake to Increase, Study Says

Editor's pick
American Journal of Managed Care
28 September 2020
PrEP policies & guidelines

UnitedHealthcare spurns Gilead's newer PrEP drug Descovy as Truvada generic looms: report

Editor's pick
FiercePharma
17 August 2020
Government, leadership & policy

MSF applauds South Africa for championing health safeguards at meeting of WTO members

Editor's pick
Reliefweb
4 August 2020
Pharmaceutical industry

Rival drugmakers' joint trial of medicines for COVID includes an experimental HIV drug

Editor's pick
Thomson Reuters Foundation
4 August 2020
Global health initiatives

Covidization of research: what are the risks?

Editor's pick
Nature
3 August 2020
Pharmaceutical industry

Gilead raises 2020 sales forecast to include revenue from COVID-19 drug remdesivir

Editor's pick
Business Today India
31 July 2020